This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
CryoPort, Inc. (CYRX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoPort (CYRX) delivered earnings and revenue surprises of -45.00% and +9.20%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Freightcar America (RAIL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Freightcar America (RAIL) delivered earnings and revenue surprises of +83.33% and +8.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Hub Group (HUBG) Beats Q2 Earnings Estimates
by Zacks Equity Research
Hub Group (HUBG) delivered earnings and revenue surprises of +2.27% and -1.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DHL Group Sponsored ADR (DHLGY) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
DHL Group Sponsored ADR (DHLGY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
CryoPort (CYRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CryoPort, Inc. (CYRX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
What Makes CryoPort, Inc. (CYRX) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does CryoPort, Inc. (CYRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
CryoPort (CYRX) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
CryoPort (CYRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts Believe CryoPort (CYRX) Could Rally 81.43%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 81.4% in CryoPort (CYRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does CryoPort (CYRX) Have the Potential to Rally 54.74% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for CryoPort (CYRX) points to a 54.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoPort (CYRX) delivered earnings and revenue surprises of 4.35% and 2.91%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Expeditors International (EXPD) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Expeditors International (EXPD) delivered earnings and revenue surprises of 13.08% and 9.95%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
CryoPort (CYRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
C.H. Robinson (CHRW) Surges 5.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
C.H. Robinson (CHRW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CryoPort (CYRX) Surges 5.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
CryoPort (CYRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoPort (CYRX) delivered earnings and revenue surprises of -27.27% and 0.46%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Global Business Travel Group, Inc. (GBTG) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Global Business Travel Group, Inc. (GBTG) delivered earnings and revenue surprises of -200% and 0.47%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Matson (MATX) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Matson (MATX) delivered earnings and revenue surprises of 18.75% and 5.48%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Avis Budget Group (CAR) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Avis Budget (CAR) delivered earnings and revenue surprises of 76.04% and 0.68%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
New Strong Buy Stocks for January 29th
by Zacks Equity Research
MC, LFST, EAT, CYRX and HCP have been added to the Zacks Rank #1 (Strong Buy) List on January 29, 2024.
CryoPort, Inc. (CYRX) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
CryoPort (CYRX) delivered earnings and revenue surprises of 92% and 2.52%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
CryoPort (CYRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CryoPort, Inc. (CYRX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
CryoPort (CYRX) delivered earnings and revenue surprises of 10.81% and 0.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Avis Budget Group (CAR) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Avis Budget (CAR) delivered earnings and revenue surprises of -84.23% and 4.01%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Hertz Global Holdings, Inc. (HTZ) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Hertz Global (HTZ) delivered earnings and revenue surprises of -19.01% and 4.96%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?